Individual #00060328

ID_report -
Reference PubMed: Peeters 1998
Remarks -
Gender -
Consanguinity -
Country South Africa
Population Pedi tribe
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases FH
Owner name Sarah Leigh
Database submission license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 InternationalCreative Commons License
Created by Johan den Dunnen
Date created 2016-04-01 19:19:06 +02:00 (CEST)
Date last edited 2020-07-14 16:02:23 +02:00 (CEST)


Phenotypes

hypercholesterolemia, familial (FH) (FH)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000046811 - - - Unknown - - - - - Sarah Leigh



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000060317 DNA SEQ - - LDLR 1 Sarah Leigh



Variants

1 entry on 1 page. Showing entry 1.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
19 Parent #1 +?/+? ACGS likely pathogenic g.11200040_11200042del g.11089364_11089366del c.-185_-183delCTT, FH Pedi-2 - LDLR_000103 predicted reduced transcription; Hobb's numbering: -92_-90del; Variant reduces activity in luciferase assay without presence of FH Pedi-1 (c.172delG, p.(Glu58Serfs*148)); DNase I footprinting indicated that this variant abolished Sp1 binding to SREBP repeat 1 in the LDLR promoter PubMed: Peeters 1998 - - Germline - - - - - Sarah Leigh LDLR - - - - 1 NM_000527.4:c.-185_-183del - r.(=) p.(=) SREBP1 binding site - - - - - - - - 5-15% LDLR activity when Htz with FH Pedi-1 (c.172delG, p.(Glu58Serfs*148)). 10% of wt luciferase activity - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.